[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced Drug Delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
N Pavlović, S Goločorbin-Kon, M Ðanić… - Frontiers in …, 2018 - frontiersin.org
Bile acids have received considerable interest in the drug delivery research due to their
peculiar physicochemical properties and biocompatibility. The main advantage of bile acids …
peculiar physicochemical properties and biocompatibility. The main advantage of bile acids …
Penetration enhancers in ocular drug delivery
There are more than 100 recognized disorders of the eye. This makes the development of
advanced ocular formulations an important topic in pharmaceutical science. One of the ways …
advanced ocular formulations an important topic in pharmaceutical science. One of the ways …
Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents
The eye presents extensive perspectives and challenges for drug delivery, mainly because
of the extraordinary capacity, intrinsic to this path, for drugs to permeate into the main …
of the extraordinary capacity, intrinsic to this path, for drugs to permeate into the main …
Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
L Li, J Hou, X Liu, Y Guo, Y Wu, L Zhang, Z Yang - Biomaterials, 2014 - Elsevier
BRAF gene mutation is found in more than 60% of malignant melanomas, which are difficult
to treat. In this study, a new tumor-targeting liposome was developed to deliver anti-BRAF …
to treat. In this study, a new tumor-targeting liposome was developed to deliver anti-BRAF …
Transfersomes: a revolutionary nanosystem for efficient transdermal drug delivery
Transdermal delivery system has gained significance in drug delivery owing to its
advantages over the conventional delivery systems. However, the barriers of stratum …
advantages over the conventional delivery systems. However, the barriers of stratum …
Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam
AM Al-Mahallawi, AA Abdelbary… - International journal of …, 2015 - Elsevier
Bilosomes represent an evolving vesicular carrier that have been explored for oral vaccines
delivery based on its ability to resist enzymes and bile salts in the gastrointestinal tract (GIT) …
delivery based on its ability to resist enzymes and bile salts in the gastrointestinal tract (GIT) …
Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease
The present study aimed at the development and evaluation of tacrolimus gellan gum
nanoparticles (TGNPs) for the effective management of dry eye disease (DED) following …
nanoparticles (TGNPs) for the effective management of dry eye disease (DED) following …
Liposomes in topical ophthalmic drug delivery: an update
Topical route of administration is the most commonly used method for the treatment of
ophthalmic diseases. However, presence of several layers of permeation barriers starting …
ophthalmic diseases. However, presence of several layers of permeation barriers starting …
Development of acetazolamide loaded bilosomes for improved ocular delivery: Preparation, characterization and in vivo evaluation
Acetazolamide (ACZ), a carbonic anhydrase inhibitor, is employed to decrease the
intraocular pressure (IOP) in glaucoma patients. ACZ is characterized by low aqueous …
intraocular pressure (IOP) in glaucoma patients. ACZ is characterized by low aqueous …